Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

234 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Responsiveness and validity in health status measurement: a clarification.
Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Guyatt GH, et al. Among authors: levine mn. J Clin Epidemiol. 1989;42(5):403-8. doi: 10.1016/0895-4356(89)90128-5. J Clin Epidemiol. 1989. PMID: 2659745 Clinical Trial.
Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer.
Reyno LM, Levine MN, Skingley P, Arnold A, Abu Zahra H. Reyno LM, et al. Among authors: levine mn. Eur J Cancer. 1992;29A(1):21-3. doi: 10.1016/0959-8049(93)90569-2. Eur J Cancer. 1992. PMID: 1445740 Clinical Trial.
A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer.
Levine MN, Bramwell V, Pritchard K, Perrault D, Findlay B, Abu-Zahra H, Warr D, Arnold A, Skillings J. Levine MN, et al. Eur J Cancer. 1992;29A(1):37-43. doi: 10.1016/0959-8049(93)90573-x. Eur J Cancer. 1992. PMID: 1445744 Clinical Trial.
A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer.
Levine MN, Gafni A, Markham B, MacFarlane D. Levine MN, et al. Ann Intern Med. 1992 Jul 1;117(1):53-8. doi: 10.7326/0003-4819-117-1-53. Ann Intern Med. 1992. PMID: 1596048
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.
Levine MN, Bramwell V, Abu-Zahra H, Goodyear MD, Arnold A, Findlay B, Skillings J, Gent M. Levine MN, et al. Br J Cancer. 1992 Jan;65(1):130-2. doi: 10.1038/bjc.1992.25. Br J Cancer. 1992. PMID: 1733435 Free PMC article. Clinical Trial.
When is a prognostic factor useful? A guide for the perplexed.
Levine MN, Browman GP, Gent M, Roberts R, Goodyear M. Levine MN, et al. J Clin Oncol. 1991 Feb;9(2):348-56. doi: 10.1200/JCO.1991.9.2.348. J Clin Oncol. 1991. PMID: 1988581 Review.
Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Turpie AG, Levine MN, Hirsh J, Ginsberg JS, Cruickshank M, Jay R, Gent M. Turpie AG, et al. Among authors: levine mn. Chest. 1990 Apr;97(4 Suppl):172S-175S. Chest. 1990. PMID: 2108855 Clinical Trial.
A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Levine M, Hirsh J, Weitz J, Cruickshank M, Neemeh J, Turpie AG, Gent M. Levine M, et al. Chest. 1990 Dec;98(6):1473-9. doi: 10.1378/chest.98.6.1473. Chest. 1990. PMID: 2123152 Clinical Trial.
Chemotherapy enhances endothelial cell reactivity to platelets.
Bertomeu MC, Gallo S, Lauri D, Levine MN, Orr FW, Buchanan MR. Bertomeu MC, et al. Among authors: levine mn. Clin Exp Metastasis. 1990 Nov-Dec;8(6):511-8. doi: 10.1007/BF00135874. Clin Exp Metastasis. 1990. PMID: 2146053
The diagnosis and treatment of thrombosis in the cancer patient.
Levine M, Hirsh J. Levine M, et al. Semin Oncol. 1990 Apr;17(2):160-71. Semin Oncol. 1990. PMID: 2183358 Review. No abstract available.
234 results
Jump to page
Feedback